{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:06:39Z","timestamp":1783483599244,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"25","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,7,7]]},"DOI":"10.1038\/s41388-025-03376-2","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T20:38:00Z","timestamp":1743799080000},"page":"2040-2053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phosphorylation enhanced OTUD3 deubiquitination ARID3A promotes the progress of cholangiocarcinoma"],"prefix":"10.1038","volume":"44","author":[{"given":"Deng-Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo-Shuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prit Benny","family":"Malgulwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-3426","authenticated-orcid":false,"given":"Zheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"3376_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73:198\u2013222.","journal-title":"CA Cancer J Clin"},{"key":"3376_CR2","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"M Vithayathil","year":"2022","unstructured":"Vithayathil M, Khan SA. Current epidemiology of cholangiocarcinoma in Western countries. J Hepatol. 2022;77:1690\u20138.","journal-title":"J Hepatol"},{"key":"3376_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2468-1253(21)00171-0","volume":"6","author":"AE Kam","year":"2021","unstructured":"Kam AE, Masood A, Shroff RT. Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol. 2021;6:956\u201369.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3376_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428\u201344.","journal-title":"Lancet."},{"key":"3376_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41392-021-00825-8","volume":"6","author":"W Li","year":"2021","unstructured":"Li W, Li F, Zhang X, Lin HK, Xu C. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment. Signal Transduct Target Ther. 2021;6:422.","journal-title":"Signal Transduct Target Ther"},{"key":"3376_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","volume":"5","author":"L Chen","year":"2020","unstructured":"Chen L, Liu S, Tao Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct Target Ther. 2020;5:90.","journal-title":"Signal Transduct Target Ther"},{"key":"3376_CR7","doi-asserted-by":"crossref","unstructured":"Guo CC, Xu HE, Ma X. ARID3a from the ARID family: structure, role in autoimmune diseases and drug discovery. Acta Pharmacol Sin. 2023;44:2139\u201350.","DOI":"10.1038\/s41401-023-01134-2"},{"key":"3376_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1182\/blood.2021014081","volume":"139","author":"JC Wheat","year":"2022","unstructured":"Wheat JC, Steidl U. Posttranscriptional Arid3a deregulation in AMKL. Blood. 2022;139:637\u20138.","journal-title":"Blood"},{"key":"3376_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104201","volume":"357","author":"ML Ratliff","year":"2020","unstructured":"Ratliff ML, Shankar M, Guthridge JM, James JA, Webb CF. TLR engagement induces ARID3a in human blood hematopoietic progenitors and modulates IFNalpha production. Cell Immunol. 2020;357:104201.","journal-title":"Cell Immunol"},{"key":"3376_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood.2021012231","volume":"139","author":"O Alejo-Valle","year":"2022","unstructured":"Alejo-Valle O, Weigert K, Bhayadia R, Ng M, Issa H, Beyer C, et al. The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis. Blood. 2022;139:651\u201365.","journal-title":"Blood"},{"key":"3376_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41419-022-05187-9","volume":"13","author":"M Shen","year":"2022","unstructured":"Shen M, Li S, Zhao Y, Liu Y, Liu Z, Huan L, et al. Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to regulate an embryonic stem cell-like gene signature. Cell Death Dis. 2022;13:732.","journal-title":"Cell Death Dis"},{"key":"3376_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/carcin\/bgaa118","volume":"42","author":"J Tang","year":"2021","unstructured":"Tang J, Yang L, Li Y, Ning X, Chaulagain A, Wang T, et al. ARID3A promotes the development of colorectal cancer by upregulating AURKA. Carcinogenesis. 2021;42:578\u201386.","journal-title":"Carcinogenesis"},{"key":"3376_CR13","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s12276-022-00887-w","volume":"54","author":"A Christine","year":"2022","unstructured":"Christine A, Park MK, Song SJ, Song MS. The equilibrium of tumor suppression: DUBs as active regulators of PTEN. Exp Mol Med. 2022;54:1814\u201321.","journal-title":"Exp Mol Med"},{"key":"3376_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10824-7","volume":"10","author":"T Du","year":"2019","unstructured":"Du T, Li H, Fan Y, Yuan L, Guo X, Zhu Q, et al. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis. Nat Commun. 2019;10:2914.","journal-title":"Nat Commun"},{"key":"3376_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27348-8","volume":"12","author":"M Wang","year":"2021","unstructured":"Wang M, Li Y, Xiao Y, Yang M, Chen J, Jian Y, et al. Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer. Nat Commun. 2021;12:7006.","journal-title":"Nat Commun"},{"key":"3376_CR16","doi-asserted-by":"publisher","first-page":"19317","DOI":"10.18632\/aging.203293","volume":"13","author":"P Xie","year":"2021","unstructured":"Xie P, Chen Y, Zhang H, Zhou G, Chao Q, Wang J, et al. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma. Aging. 2021;13:19317\u201338.","journal-title":"Aging"},{"key":"3376_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jmb.2017.02.011","volume":"429","author":"P Filipcik","year":"2017","unstructured":"Filipcik P, Curry JR, Mace PD. When worlds collide-mechanisms at the interface between phosphorylation and ubiquitination. J Mol Biol. 2017;429:1097\u2013113.","journal-title":"J Mol Biol"},{"key":"3376_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nsmb.2206","volume":"19","author":"OW Huang","year":"2012","unstructured":"Huang OW, Ma X, Yin J, Flinders J, Maurer T, Kayagaki N, et al. Phosphorylation-dependent activity of the deubiquitinase DUBA. Nat Struct Mol Biol. 2012;19:171\u20135.","journal-title":"Nat Struct Mol Biol"},{"key":"3376_CR19","doi-asserted-by":"crossref","unstructured":"Qin M, Xin Y, Bian Y, Yang X, Xi T, Xiong J. Phosphorylation-induced ubiquitination and degradation of PXR through CDK2-TRIM21 axis. Cells. 2022;11:264.","DOI":"10.3390\/cells11020264"},{"key":"3376_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/15548627.2019.1570063","volume":"15","author":"X Feng","year":"2019","unstructured":"Feng X, Jia Y, Zhang Y, Ma F, Zhu Y, Hong X, et al. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth. Autophagy. 2019;15:1130\u201349.","journal-title":"Autophagy"},{"key":"3376_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21206-3","volume":"12","author":"T Li","year":"2021","unstructured":"Li T, Wang X, Ju E, da Silva SR, Chen L, Zhang X, et al. RNF167 activates mTORC1 and promotes tumorigenesis by targeting CASTOR1 for ubiquitination and degradation. Nat Commun. 2021;12:1055.","journal-title":"Nat Commun"},{"key":"3376_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41419-023-06172-6","volume":"14","author":"DY Zhang","year":"2023","unstructured":"Zhang DY, Zhu Y, Wu Q, Ma S, Ma Y, Shen ZC, et al. USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation. Cell Death Dis. 2023;14:669.","journal-title":"Cell Death Dis"},{"key":"3376_CR23","doi-asserted-by":"publisher","first-page":"e049789","DOI":"10.1136\/bmjopen-2021-049789","volume":"12","author":"WW Liu","year":"2022","unstructured":"Liu WW, Tu JF, Ying XH, Chen ZJ, Wang YB. Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort. BMJ Open. 2022;12:e049789.","journal-title":"BMJ Open"},{"key":"3376_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1245\/s10434-018-7075-4","volume":"26","author":"TB Tran","year":"2019","unstructured":"Tran TB, Ethun CG, Pawlik TM, Schmidt C, Beal EW, Fields RC, et al. Actual 5-year survivors after surgical resection of hilar cholangiocarcinoma. Ann Surg Oncol. 2019;26:611\u20138.","journal-title":"Ann Surg Oncol"},{"key":"3376_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100737","volume":"27","author":"A Elvevi","year":"2022","unstructured":"Elvevi A, Laffusa A, Scaravaglio M, Rossi RE, Longarini R, Stagno AM, et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol. 2022;27:100737.","journal-title":"Ann Hepatol"},{"key":"3376_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cncr.34541","volume":"129","author":"KC Ohaegbulam","year":"2023","unstructured":"Ohaegbulam KC, Koethe Y, Fung A, Mayo SC, Grossberg AJ, Chen EY, et al. The multidisciplinary management of cholangiocarcinoma. Cancer. 2023;129:184\u2013214.","journal-title":"Cancer"},{"key":"3376_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cbin.11789","volume":"46","author":"Y Li","year":"2022","unstructured":"Li Y, Tang J, Li J, Du Y, Bai F, Yang L, et al. ARID3A promotes the chemosensitivity of colon cancer by inhibiting AKR1C3. Cell Biol Int. 2022;46:965\u201375.","journal-title":"Cell Biol Int"},{"key":"3376_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103200","volume":"73","author":"X Mao","year":"2024","unstructured":"Mao X, Xu J, Xiao M, Liang C, Hua J, Liu J, et al. ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. Redox Biol. 2024;73:103200.","journal-title":"Redox Biol"},{"key":"3376_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07069-9","volume":"20","author":"Q Pu","year":"2020","unstructured":"Pu Q, Lv YR, Dong K, Geng WW, Gao HD. Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells. BMC Cancer. 2020;20:583.","journal-title":"BMC Cancer"},{"key":"3376_CR30","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/s41418-020-0571-7","volume":"27","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li C, Li H, Yuan L, Dai H, Peng Z, et al. Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer. Cell Death Differ. 2020;27:3177\u201395.","journal-title":"Cell Death Differ"},{"key":"3376_CR31","doi-asserted-by":"publisher","first-page":"18629","DOI":"10.1002\/jcb.28874","volume":"120","author":"Y Jin","year":"2019","unstructured":"Jin Y, Cheng H, Cao J, Shen W. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3. J Cell Biochem. 2019;120:18629\u201339.","journal-title":"J Cell Biochem"},{"key":"3376_CR32","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s40618-021-01519-2","volume":"44","author":"M Zhao","year":"2021","unstructured":"Zhao M, Yang F, Sang C, Yan C, Wang Z. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability. J Endocrinol Investig. 2021;44:2165\u201374.","journal-title":"J Endocrinol Investig"},{"key":"3376_CR33","doi-asserted-by":"crossref","unstructured":"Lacoursiere RE, Hadi D, Shaw GS. Acetylation, phosphorylation, ubiquitination (Oh My!): following post-translational modifications on the ubiquitin road. Biomolecules. 2022;12:467.","DOI":"10.3390\/biom12030467"},{"key":"3376_CR34","doi-asserted-by":"publisher","first-page":"21036","DOI":"10.1074\/jbc.M109.016766","volume":"284","author":"T Murakami","year":"2009","unstructured":"Murakami T, Felinski EA, Antonetti DA. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem. 2009;284:21036\u201346.","journal-title":"J Biol Chem"},{"key":"3376_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.molcel.2018.01.009","volume":"69","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Mudge MC, Soll JM, Rodrigues RB, Byrum AK, Schwarzkopf EA, et al. OTUD4 is a phospho-activated K63 deubiquitinase that regulates MyD88-dependent signaling. Mol Cell. 2018;69:505\u201316.e5.","journal-title":"Mol Cell"},{"key":"3376_CR36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.cmet.2022.05.005","volume":"34","author":"N Zhou","year":"2022","unstructured":"Zhou N, Qi H, Liu J, Zhang G, Liu J, Liu N, et al. Deubiquitinase OTUD3 regulates metabolism homeostasis in response to nutritional stresses. Cell Metab. 2022;34:1023\u201341.e8.","journal-title":"Cell Metab"},{"key":"3376_CR37","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/ncb3396","volume":"18","author":"A Zhou","year":"2016","unstructured":"Zhou A, Lin K, Zhang S, Chen Y, Zhang N, Xue J, et al. Nuclear GSK3beta promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22. Nat Cell Biol. 2016;18:954\u201366.","journal-title":"Nat Cell Biol"},{"key":"3376_CR38","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.7150\/thno.38711","volume":"10","author":"S Zhang","year":"2020","unstructured":"Zhang S, Gao W, Tang J, Zhang H, Zhou Y, Liu J, et al. The roles of GSK-3beta in regulation of retinoid signaling and sorafenib treatment response in hepatocellular carcinoma. Theranostics. 2020;10:1230\u201344.","journal-title":"Theranostics"},{"key":"3376_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/mds.25824","volume":"29","author":"E Tolosa","year":"2014","unstructured":"Tolosa E, Litvan I, Hoglinger GU, Burn D, Lees A, Andres MV, et al. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Mov Disord J Mov Disord Soc. 2014;29:470\u20138.","journal-title":"Mov Disord J Mov Disord Soc"},{"key":"3376_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41419-023-05900-2","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Du T, Liu N, Wang J, Zhang L, Cui CP, et al. Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer. Cell Death Dis. 2023;14:378.","journal-title":"Cell Death Dis"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03376-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T22:02:48Z","timestamp":1750024968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03376-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":40,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025,7,7]]}},"alternative-id":["3376"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03376-2","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This animal study was approved by the Animal Ethics Committee of Bengbu Medical College (No. 2021298). This study was approved by the Bengbu Medical College Ethics Committee (No. 2021230). All methods were performed in accordance with the relevant guidelines and regulations. The informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}